| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Clearside Biomedical, Inc. (CLSDQ) has 0 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. CLSDQ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2022 | Lasezkay George M71 | CEO | Sell | 10,800 | $2.12 | $22,896.00 | -2.1% | -7.1% | -30.3% | |
| Jan 11, 2022 | Lasezkay George M71 | CEO | Sell | 5,100 | $2.46 | $12,546.00 | -1.2% | -13.4% | -33.7% | |
| Sep 21, 2021 | Ciulla Thomas72 | Chief Medical Officer | Sell | 2,560 | $6.40 | $16,384.00 | -1.0% | -55.5% | -82.3% | |
| Sep 21, 2021 | Lasezkay George M71 | CEO | Sell | 3,525 | $6.46 | $22,771.50 | -0.8% | -55.5% | -82.3% | |
| Sep 21, 2021 | Deignan Charles A.69 | Chief Financial Officer | Sell | 2,800 | $6.41 | $17,948.00 | -0.9% | -55.5% | -82.3% | |
| Sep 1, 2021 | Whitmore Bradford T76 | 10% Owner | Sell | 420,285 | $6.95 | $2,920,426.86 | -5.1% | -45.3% | -79.6% | |
| Aug 16, 2021 | Hutson Nancy J58 | Director | Buy | 3,000 | $5.68 | $17,040.00 | +30.0% | -13.7% | -72.7% | |
| Jun 21, 2021 | Lasezkay George M71 | CEO | Sell | 3,707 | $4.38 | $16,236.66 | -0.9% | +40.8% | -65.4% | |
| Jun 21, 2021 | Deignan Charles A.69 | Chief Financial Officer | Sell | 2,938 | $4.37 | $12,839.06 | -0.9% | +40.8% | -65.4% | |
| Mar 19, 2021 | Lasezkay George M71 | CEO | Sell | 3,370 | $2.82 | $9,503.40 | -0.8% | +69.3% | -4.4% |